Profil
William Earnest Pullman is currently a Director at Proximagen Group Plc and a Director at USL Pharma International UK Ltd. He previously worked as the Chief Medical Officer & Senior Vice President at Cubist Pharmaceuticals LLC, the Chief Development Officer & Executive VP at Dyax Corp., and the Senior Vice President-Exploratory Development at TransForm Pharmaceuticals, Inc. Pullman holds a doctorate degree from both the Australian National University and The University of Western Australia.
Aktive Positionen von William Earnest Pullman
| Unternehmen | Position | Beginn |
|---|---|---|
USL Pharma International UK Ltd.
USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops drugs for the treatment of neurological and inflammatory disorders | Direktor/Vorstandsmitglied | 18.12.2013 |
Proximagen Group Ltd.
Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Direktor/Vorstandsmitglied | 18.12.2013 |
Ehemalige bekannte Positionen von William Earnest Pullman
| Unternehmen | Position | Ende |
|---|---|---|
| DYAX CORP. | Technik-/Wissenschafts-/F&E-Leiter | - |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Corporate Officer/Principal | - |
| CUBIST PHARMACEUTICALS INC | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von William Earnest Pullman
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 7 |
|---|---|
Cubist Pharmaceuticals LLC
Cubist Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of pharmaceutical products | Health Technology |
Dyax Corp.
Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Proximagen Group Ltd.
Proximagen Group Ltd. Pharmaceuticals: MajorHealth Technology Develops novel therapeutics designed for the treatment of central nervous system diseases | Health Technology |
Australian National University
Australian National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
TransForm Pharmaceuticals, Inc.
TransForm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs | Health Technology |
The University of Western Australia
The University of Western Australia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
USL Pharma International UK Ltd.
USL Pharma International UK Ltd. Pharmaceuticals: MajorHealth Technology Operates as holding company whose subsidiaries develops drugs for the treatment of neurological and inflammatory disorders | Health Technology |
















